Development and clinical feasibility study of a brief version of an addiction‐focused phenotyping battery in females receiving buprenorphine for opioid use disorder

INTRODUCTION: We aimed to streamline the NIDA Phenotyping Assessment Battery (PhAB), a package of self‐report scales and neurobehavioral tasks used in substance use disorder (SUD) clinical trials, for clinical administration ease. Tailoring the PhAB to shorten administration time for a treatment set...

Descripción completa

Detalles Bibliográficos
Autores principales: Parlier‐Ahmad, Anna Beth, Eglovitch, Michelle, Legge, Catherine, Keyser‐Marcus, Lori A., Bjork, James M., Adams, Amanda, Ramey, Tanya, Moeller, Frederick Gerard, Martin, Caitlin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454248/
https://www.ncbi.nlm.nih.gov/pubmed/37367725
http://dx.doi.org/10.1002/brb3.3128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454248/
https://www.ncbi.nlm.nih.gov/pubmed/37367725
http://dx.doi.org/10.1002/brb3.3128

Ejemplares similares